News
The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...
In multiple experiments, C-a16 lipids, which contain a phenol group, outperformed LNPs used in currently available mRNA ...
Using machine learning, OmicsTweezer merges diverse data by using deep learning combined with optimal transport.
ImP administration to mouse model induced atherosclerosis without altering the lipid profile, and was associated with immune ...
GenesisM’s enhanced core platform is designed to provide long-term operational flexibility and accelerate buildout timeline.
Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the ...
David Baker’s lab has successfully designed binders to disordered proteins, expanding therapeutic access to over 50% of the human proteome.
Eight babies, born following Mitochondrial Donation treatment to reduce transmission of mitochondrial DNA disease, show no ...
Thermo Fisher will expand use of the Sanofi site to meet the demand from pharma and biotech customers for U.S. manufacturing capacity.
The portrayal of uncaring scientists without any thought for the animals being used in their research is far from the truth.
Three years after spinning out from the University of Glasgow, Chemify has opened its first fully automated facility that marries chemistry, AI, computation, and robotics near the school in the city’s ...
Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results